School of Medicine news release | RVCL Research Center

Decades of dedication lead to drug trial for rare, fatal illness (Links to an external site)

June 19, 2018January 9, 2023

Article explores the research efforts to develop therapies for RVCL and the clinical trial evaluating the use of an old cancer drug to treat this devastating blood vessel disease.

$4.1 million Clayco Foundation gift aids research into rare disease (Links to an external site)

January 4, 2016January 9, 2023

A $4.1 million gift from The Clayco Foundation will advance research led by John P. Atkinson, MD, into a rare but deadly blood vessel disease called cerebroretinal vasculopathy.